Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11746120 Stat degraders and uses thereof

Patent 11746120 was granted and assigned to Kymera Therapeutics on September, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
Kymera Therapeutics
Kymera Therapeutics
Date Filed
October 10, 2022
Date of Patent
September 5, 2023
Patent Applicant
Kymera Therapeutics
Kymera Therapeutics
Patent Application Number
18045390
Patent Citations
‌
US Patent 7402325 Supercritical carbon dioxide extract of pharmacologically active components from
‌
US Patent 7449458 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
‌
US Patent 7501496 Anti-OX40L antibodies
‌
US Patent 7514444 Inhibitors of bruton's tyrosine kinase
‌
US Patent 7528143 Bi-aryl meta-pyrimidine inhibitors of kinases
‌
US Patent 7557210 2,4-pyrimidinediamine compounds and their uses
‌
US Patent 7598257 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
‌
US Patent 7622496 Modified lysine-mimetic compounds
‌
US Patent 7667039 1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitors
‌
US Patent 7713943 Further use of protein kinase N beta
•••
Patent Citations Received
‌
US Patent 12077555 STAT degraders and uses thereof
0
Patent Inventor Names
Nan Ji
Yi Zhang
Nello Mainolfi
Bin Yang
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11746120
Patent Primary Examiner
‌
Po-Chih Chen

Find more entities like US Patent 11746120 Stat degraders and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo